Comparison

Adrixetinib European Partner

Item no. HY-152830-1mg
Manufacturer MedChem Express
CASRN 2394874-66-7
Amount 1 mg
Category
Type Inhibitors
Specific against other
Purity 99.51
Formula C25H24F3N5O5
Citations [1]WHO Drug Informat ion - World Health Organization (WHO).<br>[2]Nam Kiyean, et al. Quinoline derivatives as inhibitors of Axl/Mer RTK and CSF1R and their preparation: World Intellectual Property Organization, WO2019229251. 2019-12-05.<br>[3]WHO Drug Information-World Health Organization (WHO).
Smiles O=C(C1=NN(CCC)C=C1OCC(F)(F)F)NC2=NC=C(C=C2)OC3=C4C=C(OC)C(OC)=CC4=NC=C3
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Q702
Available
Product Description
Adrixetinib is an inhibitor of protein tyrosine kinase with antineoplastic activity[1][2].
StorageTemperature
4°C (Powder, sealed storage, away from moisture and light)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
531.48
Clinical_Information
Phase 2
Manufacturers Research_Area
Cancer
Solubility
DMSO : ≥ 100 mg/mL
Pathway
Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close